Anti-CEECAM1 antibody [EPR13744] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CEECAM1 antibody. Carrier free. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CEECAM1, GLT25D3, KIAA1502, CERCAM, Inactive glycosyltransferase 25 family member 3, Cerebral endothelial cell adhesion molecule
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CEECAM1 antibody [EPR13744] - BSA and Azide free (AB250547)
This data was developed using ab181979, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed 293 cells labeling CEECAM1 with ab181979 at 1/300 dilution (red) compared to a Rabbit monoclonal IgG Isotype control (greeen), followed by Goat anti rabbit IgG (FITC) secondary antibody at 1/150 dilution.
- WB
Supplier Data
Western blot - Anti-CEECAM1 antibody [EPR13744] - BSA and Azide free (AB250547)
This data was developed using ab181979, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-CEECAM1 antibody [EPR13744] (<a href='/en-us/products/primary-antibodies/ceecam1-antibody-epr13744-ab181979'>ab181979</a>) at 1/10000 dilution
Lane 1:
Human fetal brain lysate at 20 µg
Lane 2:
Jurkat cell lysate at 20 µg
Lane 3:
293 cell lysate at 20 µg
Lane 4:
U87-MG cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 68 kDa
Observed band size: 68 kDa
false
Related conjugates and formulations (1)
-
Anti-CEECAM1 antibody [EPR13744]
Reactivity data
Product details
ab250547 is the carrier-free version of ab181979.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CEECAM1 participates in modulating immune responses and cellular proliferation. This protein interacts with other molecules at the cell surface to form complexes that influence cell signaling pathways. CEECAM1's involvement in processes such as cell adhesion and migration makes it significant in tissue architecture and homeostasis. Through these functions CEECAM1 has an influence on both normal physiological processes and pathological conditions.
Pathways
CEECAM1 is actively involved in the MAPK and PI3K/AKT signaling pathways. These pathways are critical for transmitting signals related to growth survival and differentiation of cells. In the MAPK pathway CEECAM1 interacts with proteins like ERK which regulates various cellular activities. Within the PI3K/AKT pathway CEECAM1 can influence activity impacting cell cycle progression and apoptosis. Its interactions within these pathways link CEECAM1 to a broader network of cellular functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 26:458 PubMed37736555
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com